510(k) Report

510(k) · Cleared

Cleared

Dimertest

K080069510(k) TraditionalCleared Feb 13, 200834-day reviewClass II21 CFR 864.7320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

American Diagnostica, Inc. · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Cleared on Feb 13, 2008 as substantially equivalent to K882944 (Agen Biomedical, Ltd., 1988) after a 34-day review. Its family tree reaches back 1 generation to 1988.

Decided
Feb 13, 2008
Review
34 days
Class
Class II
Product code
DAP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K882944 (1988). No later device cites it as a predicate yet.

K882944 · Dimertest (R) Latex · Agen Biomedical, Ltd. · 19880
  1. Root · 1 generation backK882944 Dimertest (R) LatexAgen Biomedical, Ltd. · 1988
  2. This deviceK080069 DimertestAmerican Diagnostica, Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K882944Dimertest (R) LatexAgen Biomedical, Ltd.1988—
0 (this device)K080069DimertestAmerican Diagnostica, Inc.2008—
FIG. 1 — Lineage of K080069, 1988–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DAP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DAP device

  1. #1 K253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)score 13.0 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K882944Dimertest (R) Latex
Summary page 1
…DI. The performance characteristics of the modified DIMERTEST ® product and a summary of the modifications made to the DIMERTEST ® product that had been cleared in 1988 (K882944) are described in the DIMERTEST® 510(k) submission K974596. C. Measurand: D-Dimer D. Type of Test: Latex Immuno Assay E. Appli…
Agen Biomedical, Ltd.1988—
†K945642Agen Dimertest Gold EiaAgen Biomedical, Ltd.1995—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All DAP devices

DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · DAP

1in 2017

2007: 22008: 32009: 12010: 22011: 12012: 12014: 12015: 12016: 22017: 12026 (partial year): 1
2007high 3 (2008) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DAP

127in 2008

2008: 127 days median
2007high 127 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DAP

2in 2025

2015: 12021: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DAP

2in 2025

2007: 42008: 102009: 132010: 92011: 142012: 102013: 82014: 92015: 382016: 202017: 172018: 52019: 92020: 112021: 72022: 302023: 42024: 12025: 2
2007high 38 (2015) · low 1 (2024)2025

MAUDE reports naming product code DAP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—04
20083127010
20091—013
20102—09
20111—014
20121—010
20130—08
20141—09
20151—138
20162—020
20171—017
20180—05
20190—09
20200—011
20210—17
20220—030
20230—04
20240—01
20250—22
20261—0—

What is it indicated for?

The DIMERTEST® Latex Assay is intended for the rapid qualitative or semi-quantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (D-dimer) in human plasma.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080069: Dimertest.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K080069

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026